A potential therapeutic strategy for prostatic disease by targeting the oral microbiome.

Fang, Cheng; Wu, Lan; Zhu, Cong; Xie, Wen-Zhong; Hu, Hailiang; Zeng, Xian-Tao

Fang, Cheng; Wu, Lan; Zhu, Cong; Xie, Wen-Zhong; Hu, Hailiang; Zeng, Xian-Tao.

Afiliación

Fang C; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Wu L; Department of Stomatology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Zhu C; Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Xie WZ; Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
Hu H; Department of Stomatology, Kaifeng University Health Science Center, Kaifeng, Henan, China.
Zeng XT; Department of Pathology, Duke University School of Medicine, Durham, North Carolina, USA.

Med Res Rev ; 41(3): 1812-1834, 2021 05.

Article en En | MEDLINE | ID: mdl-33377531

Asunto(s)

Microbiota; Enfermedades de la Próstata; Neoplasias de la Próstata; Humanos; Masculino

Palabras clave

benign prostatic hyperplasia; oral microbiome; periodontal disease; prostate cancer; prostatitis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades de la Próstata / Neoplasias de la Próstata / Microbiota Límite: Humans / Male Idioma: En Revista: Med Res Rev Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google